Entries by CAPTIS

BIO Chimes In: Impression Products v. Lexmark International (Supreme Court)

This is a three part series on BIO’s recently submitted amicus briefs in cases before the Supreme Court as well as the U.S. Court of Appeals for the Federal Circuit. Included in our cases to watch post were some upcoming IP cases on the agenda this term for the Supreme Court.  BIO, with Croplife International, has subsequently […]

Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area's GRAIL Banks $900 Million

March 2, 2017By Alex Keown, BioSpace.com Breaking News Staff MENLO PARK, Calif. – Grail Inc., a company focused on using diagnostics to develop early-stage cancer detection, just bagged $900 million in Series B financing. The company, helmed by Jeff Huber, a widower whose wife died from cancer, will use the proceeds to continue product development […]

NxStage Medical, Inc. Announces CE Mark For Its NxGen Hemodialysis System

LAWRENCE, Mass., March 2, 2017 /PRNewswire/ — NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received CE Mark approval.  This innovative system consists of new features and capabilities, including a new touchscreen user interface and integrated blood pressure monitor designed […]

Alere's Bad News Tests The Limits Of Everyone's Patience

Not again. Alere Inc., the beleaguered medical-test maker, can’t seem to go very long without divulging more bad news — and that’s as it tries to force Abbott Laboratories to follow through on an $8.4 billion takeover offer. This week, Alere Inc. said that it’s still working through the material weaknesses in its internal accounting controls that […]

Sartorius Pays $320 Million Cash to Take Out Essen BioScience

Sartorius AG: * Sartorius to acquire real-time live-cell analysis pioneer and leader Essen BioScience * Transaction, which is subject to antitrust clearance, is expected to close by end of Q1 2017 * Sartorius will purchase Essen BioScience for $320 million in cash * Sartorius will update its 2017 financial guidance for lab division and therefore […]

Halyard Health: Transformation Into a Medical Device Company Increases Takeover Odds

Halyard Health (NYSE:HYH), a company that provides health and healthcare supplies including surgical and infection prevention (“S&IP”) and medical devices, continues to transform towards higher margin medical devices while attempting to stabilize is lower margin price sensitive S&IP division. The company’s most recent quarterly results exceeded analyst revenue and earnings estimates while the company also […]

Alcami Invests In Bruker's D8 DISCOVER HTS System For High-Throughput X-Ray Diffraction Screening In Pharmaceutical Formulation Development

WEERT, Netherlands and KARLSRUHE, Germany, March 3, 2017 /PRNewswire/ — Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, and Bruker AXS, one of the world’s leading suppliers of analytical X-ray solutions, today announced the delivery of Bruker’s D8 DISCOVER HTS high-throughput X-ray Diffraction (XRD) analysis system to the Alcami […]

FDA approves CeloNova’s Cobra PzF stent system

MDBR Staff Writer Published 02 March 2017 CeloNova BioSciences has secured approval from the US Food and Drug Administration (FDA) for its Cobra PzF nanocoated coronary stent system. The approval was based on results from the PzF Shield clinical study, which met its primary safety and effectiveness endpoints at nine-month follow-up. The trial showed no […]

BIOLASE Inc. Names Chief Financial Officer

IRVINE, Calif.–(BUSINESS WIRE)–BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has appointed veteran financial executive Mark J. Nelson as its Senior Vice President and Chief Financial Officer, effective March 27, 2017. He will report to BIOLASE President and CEO Harold C. Flynn, Jr. and replaces David C. Dreyer, who resigned […]